CHICAGO--(BUSINESS WIRE)--Cardiosense, a digital health company pioneering AI-enabled solutions for cardiac disease management, today announced the appointment of Eric Meizlish as Chief Executive ...

The Food and Drug Administration has cleared Cardiosense’s CardioTag wearable heart monitor, the company said Wednesday. CardioTag captures electrocardiogram, photoplethysmogram and seismocardiogram ...

Cardiosense has hired Eric Meizlish as CEO to oversee the growth of its recently cleared wearable heart monitor. The company, which disclosed the appointment last week, has recruited Meizlish to ...

Cardiovascular disease is a leading cause of death, with over 900,00 deaths reported in the United States in 2023. In this context many companies have pursued products to help diagnose or sense heart ...

Cardiosense has received U.S. Food & Drug Administration clearance for a wearable sensor that can measure multiple cardiac signals. The FDA 510(k) clearance for CardioTag will allow the company to ...

The FDA isn’t the only one with its eye on Cardiosense’s artificial intelligence algorithms, which are aiming to predict heart disease before it develops. Just a few months after nabbing the regulator ...

Eric Meizlish, co-founder of clinical analysis company Lumere, has been tapped to lead cardiac-focused digital health company Cardiosense. He will succeed Chicago-based Cardiosense's co-founder Amit ...

Chicago-based Cardiosense has received 510(k) clearance from the FDA for its CardioTag device, a multimodal wearable sensor. The CardioTag is designed to provide clinicians with a comprehensive, ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance for CardioTag, Cardiosense’s multimodal, wearable sensor. Aimed at cardiac function monitoring, the device is said to capture ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Cardiosense's innovative heart ...

CHICAGO, Nov. 20, 2024 /PRNewswire/ -- Cardiosense, a medical AI company transforming the diagnosis and management of cardiac disease, announced the presentation of results from its SEISMIC-HF I study ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Cardiosense brings in a new CEO ...